Abstract
Since the human genome has been fully sequenced, and presence of single nucleotide polymorphisms (SNPs) appeared abundant, many studies are associating SNPs with clinical response or even with disease. For some diseases or drug treatments these associations are clear, so that genetic screening for such SNPs or mutations is a standard procedure. For that reason, many different techniques have been developed for fast and easy screening for such specific SNPs/mutations. For reliable screening, the use of controls with known genotypes is indispensable. Plasmids are an ideal tool for making controls which can serve as an inexhaustible source, making new validation superfluous.
In this chapter we describe how plasmid controls can be made using DNA with a heterozygous genotype, and also from DNA of which only one allele is available.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Sanger F, Coulson AR (1975) A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 94:441–448
van der Heiden I, van der Werf M et al (2004) Sequencing: not always the “gold standard”. Clin Chem 50:248–249
van der Straaten T, Swen J et al (2008) Use of plasmid-derived external quality control samples in pharmacogenetic testing. Pharmacogenomics 9:1261–1266
van der Straaten T, van Schaik RH (2010) Genetic techniques for pharmacogenetic analyses. Curr Pharm Des 16:231–237
Ullmann A, Jacob F, Monod J (1967) Characterization by in vitro complementation of a peptide corresponding to an operator-proximal segment of the beta-galactosidase structural gene of Escherichia coli. J Mol Biol 24:339–343
Yanisch-Perron C, Vieira J, Messing J (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103–119
Mezei LM, Storts DR (1994) Purifications of PCR products. In: Griffin HG, Griffin AM (eds) PCR technology: current innovations. CRC, Boca Raton, p 21
Robles J, Doers M (1994) pGEM-T Vector Systems troubleshooting guide. Promega Notes 45:19–20
Clark JM (1988) Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. Nucleic Acids Res 16:9677–9686
Mandel M, Higa A (1970) Calcium-dependent bacteriophage DNA infection. J Mol Biol 53:159–162
Dagert M, Ehrlich SD (1979) Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene 6:23–28
Ausubel FM (1997) Current protocols in molecular biology. Wiley, New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
van der Straaten, T., Guchelaar, HJ. (2013). Plasmid Derived External Quality Controls for Genetic Testing. In: Innocenti, F., van Schaik, R. (eds) Pharmacogenomics. Methods in Molecular Biology, vol 1015. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-435-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-62703-435-7_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-434-0
Online ISBN: 978-1-62703-435-7
eBook Packages: Springer Protocols